Shorts

0:38
A Unique Inhibitor: Why This Cancer Drug is Different
5 months ago
by
Sara A. Hurvitz, MD

1:12
Dr Kalinsky Talks Updates in Lobular Carcinoma
5 months ago
by
Kevin Kalinsky, MD, MS

0:32
Could a Breakthrough in Pancreatic Cancer Change Breast Cancer Treatment?
5 months ago
by
Paolo Tarantino, MD

0:40
Why ADCs Are Changing Breast Cancer Treatment
5 months ago
by
Paolo Tarantino, MD

0:45
Can Targeted Therapies Redefine DLBCL Treatment?
5 months ago
by
Sonali M. Smith, MD

0:37
Don’t Reinvent the Wheel: Peer Insights for Advanced Therapies
6 months ago
by
Fran Gregory, PharmD, MBA

0:45
New Breast Cancer Trial Results: Omitting Surgery is Safe
6 months ago
by
Jana de Boniface, MD

0:40
Glossary Break: PFS vs OS
6 months ago
by
Sabrina Serani

0:50
Glossary Break: All About Biomarkers
6 months ago
by
Sabrina Serani

0:25
ASCO 2026: Brain Fog & Prostate Cancer Treatment
6 months ago
by
Sabrina Serani

0:30
Dr Herzberg Talks Updates in KRAS-Mutant NSCLC
6 months ago
by
Benjamin Herzberg, MD

0:42
The Future of Breast Cancer Treatment: Escalation vs De-Escalation
6 months ago
by
Javier Cortés, MD, PhD

1:04
Glossary Break: All About Liquid Biopsies
6 months ago
by
Sabrina Serani

0:39
Navigating Financial Complexity of Advanced Therapies: A Role for Specialty Pharmacy
6 months ago
by
Fran Gregory, PharmD, MBA

0:49
Coordinating Care When Every Minute Matters
6 months ago
by
Fran Gregory, PharmD, MBA

0:30
Building the Foundation for Advanced Therapy Delivery in the Community
6 months ago
by
Fran Gregory, PharmD, MBA

0:41
180 Advanced Therapies by 2030—Are Clinicians Ready?
6 months ago
by
Fran Gregory, PharmD, MBA

0:30
BRIDGE: An Integrated Platform for Early-Onset Cancer Research and Care
6 months ago
by
W. Kimryn Rathmell, MD, PhD

0:37
National Study Affirms Value of Community Oncology
6 months ago
by
Diana Verrilli, MS

0:43
Bridging Oncology Silos to Improve Early-Onset Cancer Care
6 months ago
by
W. Kimryn Rathmell, MD, PhD

0:30
How Genome Sequencing Changed Cancer Research
6 months ago
by
Joyce Ohm, PhD

0:31
Is Knowing Too Much About Your DNA Actually Dangerous?
6 months ago
by
Joyce Ohm, PhD

0:28
From Generic to Personalized Cancer Care in Hours
6 months ago
by
Joyce Ohm, PhD

0:50
A New Early-Onset Cancer Program Is Coordinating Fragmented Care
6 months ago
by
W. Kimryn Rathmell, MD, PhD

0:52
Why Early-Onset Cancer Cases Deserve Attention
6 months ago
by
W. Kimryn Rathmell, MD, PhD

1:00
Can Engineering Stem Cells to Prevent GVHD Save Health Systems Money?
6 months ago
by
Rawan G. Faramand, MD

0:58
60% of Early-Onset Cancers May Be Screenable
6 months ago
by
W. Kimryn Rathmell, MD, PhD

0:38
Does Weight Change How Cancer Cells Behave?
6 months ago
by
Roberto Borea, MD

0:38
One Child Cured Equals Decades of Life Saved
6 months ago
by
E. Anders Kolb, MD(+1 more)

0:36
A Powerful New Way to Measure Cancer Success
6 months ago
by
E. Anders Kolb, MD(+1 more)
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
2
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
3
FDA Approves Giredestrant Plus Everolimus in ESR1-Mutated Breast Cancer
4
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
5
